Literature DB >> 30830209

What Every Neuropathologist Needs to Know: Update on cIMPACT-NOW.

Gabrielle A Yeaney1, Daniel J Brat2.   

Abstract

World Health Organization (WHO) central nervous system tumor classification represents the primary source of updates on diagnostic classes, grades, and criteria. However, recent and ongoing advances in molecular pathogenesis warrant more rapid integration into clinical practice between WHO updates. To accomplish this, the consortium to inform molecular and practical approaches to CNS tumor taxonomy-not official WHO (cIMPACT-NOW) was established in 2016. Since then, cIMPACT-NOW has convened 3 separate working committees to address classification and grading questions and challenges. This review covers the progress that these working committees have made on their specific topics.
© 2019 American Association of Neuropathologists, Inc. All rights reserved.

Entities:  

Keywords:  Brain tumor; CNS neoplasm; Consortium; Molecular; Taxonomy; WHO classification; cIMPACT

Year:  2019        PMID: 30830209     DOI: 10.1093/jnen/nlz012

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  5 in total

Review 1.  The cIMPACT-NOW updates and their significance to current neuro-oncology practice.

Authors:  L Nicolas Gonzalez Castro; Pieter Wesseling
Journal:  Neurooncol Pract       Date:  2020-08-29

Review 2.  A Practical Approach to the Differential Diagnosis of Intracranial Tumors: Gross, Histology, and Immunoprofile-based Algorithm.

Authors:  George S Stoyanov; Lilyana Petkova; Deyan L Dzhenkov
Journal:  Cureus       Date:  2019-12-15

3.  Improving the noninvasive classification of glioma genetic subtype with deep learning and diffusion-weighted imaging.

Authors:  Julia Cluceru; Yannet Interian; Joanna J Phillips; Annette M Molinaro; Tracy L Luks; Paula Alcaide-Leon; Marram P Olson; Devika Nair; Marisa LaFontaine; Anny Shai; Pranathi Chunduru; Valentina Pedoia; Javier E Villanueva-Meyer; Susan M Chang; Janine M Lupo
Journal:  Neuro Oncol       Date:  2022-04-01       Impact factor: 13.029

4.  The Korean Society for Neuro-Oncology (KSNO) Guideline for WHO Grade II Cerebral Gliomas in Adults: Version 2019.01.

Authors:  Do Hoon Lim; Dong Sup Chung; Young Zoon Kim; Chae Yong Kim; Chan Woo Wee; Tae Hoon Roh; Je Beom Hong; Hyuk Jin Oh; Seok Gu Kang; Shin Hyuk Kang; Doo Sik Kong; Sung Hwan Kim; Se Hyuk Kim; Se Hoon Kim; Yu Jung Kim; Eui Hyun Kim; In Ah Kim; Ho Sung Kim; Jae Sung Park; Hyun Jin Park; Sang Woo Song; Kyoung Su Sung; Seung Ho Yang; Wan Soo Yoon; Hong In Yoon; Jihae Lee; Soon Tae Lee; Sea Won Lee; Youn Soo Lee; Jaejoon Lim; Jong Hee Chang; Tae Young Jung; Hye Lim Jung; Jae Ho Cho; Seung Hong Choi; Hyoung Soo Choi
Journal:  Brain Tumor Res Treat       Date:  2019-10

5.  Reclassification of Glioblastoma Multiforme According to the 2021 World Health Organization Classification of Central Nervous System Tumors: A Single Institution Report and Practical Significance.

Authors:  George S Stoyanov; Emran Lyutfi; Reneta Georgieva; Radoslav Georgiev; Deyan L Dzhenkov; Lilyana Petkova; Borislav D Ivanov; Ara Kaprelyan; Peter Ghenev
Journal:  Cureus       Date:  2022-02-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.